1
|
Panasenko OM, Ivanov VA, Mikhalchik EV, Gorudko IV, Grigorieva DV, Basyreva LY, Shmeleva EV, Gusev SA, Kostevich VA, Gorbunov NP, Sokolov AV. Methylglyoxal-Modified Human Serum Albumin Binds to Leukocyte Myeloperoxidase and Inhibits its Enzymatic Activity. Antioxidants (Basel) 2022; 11:2263. [PMID: 36421449 PMCID: PMC9686918 DOI: 10.3390/antiox11112263] [Citation(s) in RCA: 2] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/16/2022] [Revised: 11/01/2022] [Accepted: 11/10/2022] [Indexed: 11/15/2023] Open
Abstract
Hyperglycemia in diabetes mellitus induces modification of proteins by glucose and its derivative methylglyoxal (MG). Neutrophils perform their bactericidal activity mainly via reactive halogen (RHS) and oxygen (ROS) species generation catalyzed by myeloperoxidase (MPO) stored in neutrophil azurophilic granules (AGs) and membrane NADPH oxidase, respectively. Herein, we study the binding of human serum albumin (HSA) modified with MG (HSA-MG) to MPO and its effects on MPO activity and release by neutrophils. Peroxidase activity of MPO was registered by oxidation of 2,2'-azino-bis(3-ethylbenzothiazoline-6-sulfonic acid) diammonium salt, and chlorinating activity by decolorization of Celestine blue B dye. Binding of HSA-MG to MPO was studied by affinity chromatography, disc-electrophoresis, ligand Western blotting and enzyme-linked solid phase immunoassay using monoclonal antibodies (mAbs) to MPO. ROS and RHS generation were detected by lucigenin (Luc) and luminol (Lum) chemiluminescence (CL), respectively. Neutrophil degranulation was assessed by flow cytometry using fluorescent labeled antibodies to the marker proteins CD63 from AGs and CD11b from peroxidase-negative granules (PNGs). NETosis was assayed by quantifying DNA network-like structures (NET-like structures) in blood smears stained by Romanowsky. HSA-MG bound to MPO, giving a stable complex (Kd = 1.5 nM) and competing with mAbs, and non-competitively inhibited peroxidase and chlorinating MPO activity and induced degranulation of PNGs but not of AGs. HSA-MG enhanced Luc-CL per se or following PMA, unlike Lum-CL, and did not affect spontaneous or PMA-stimulated NETosis. Thus, HSA modified under hyperglycemia-like conditions stimulated NADPH oxidase of neutrophils but dampened their functions dependent on activity of MPO, with no effect on its release via degranulation or NETosis. This phenomenon could underlie the downregulation of bactericidal activity of MPO and neutrophils, and hence of innate immunity, giving rise to wound healing impairment and susceptibility to infection in patients with hyperglycemia.
Collapse
Affiliation(s)
- Oleg M. Panasenko
- Department of Biophysics, Federal Research and Clinical Center of Physical-Chemical Medicine of Federal Medical Biological Agency, Moscow 119435, Russia
- Department of Medical Biophysics of the Institute for Translative Medicine, Pirogov Russian National Research Medical University, Moscow 117997, Russia
| | - Viktor A. Ivanov
- Department of Biophysics, Federal Research and Clinical Center of Physical-Chemical Medicine of Federal Medical Biological Agency, Moscow 119435, Russia
| | - Elena V. Mikhalchik
- Department of Biophysics, Federal Research and Clinical Center of Physical-Chemical Medicine of Federal Medical Biological Agency, Moscow 119435, Russia
| | - Irina V. Gorudko
- Department of Biophysics, Belarusian State University, 220030 Minsk, Belarus
| | - Daria V. Grigorieva
- Department of Biophysics, Belarusian State University, 220030 Minsk, Belarus
| | - Liliya Yu. Basyreva
- Department of Biophysics, Federal Research and Clinical Center of Physical-Chemical Medicine of Federal Medical Biological Agency, Moscow 119435, Russia
| | - Ekaterina V. Shmeleva
- Department of Biophysics, Federal Research and Clinical Center of Physical-Chemical Medicine of Federal Medical Biological Agency, Moscow 119435, Russia
| | - Sergey A. Gusev
- Department of Biophysics, Federal Research and Clinical Center of Physical-Chemical Medicine of Federal Medical Biological Agency, Moscow 119435, Russia
| | - Valeria A. Kostevich
- Department of Biophysics, Federal Research and Clinical Center of Physical-Chemical Medicine of Federal Medical Biological Agency, Moscow 119435, Russia
- Department of Molecular Genetics, Institute of Experimental Medicine, St. Petersburg 197376, Russia
| | - Nikolay P. Gorbunov
- Department of Biophysics, Federal Research and Clinical Center of Physical-Chemical Medicine of Federal Medical Biological Agency, Moscow 119435, Russia
- Department of Molecular Genetics, Institute of Experimental Medicine, St. Petersburg 197376, Russia
| | - Alexey V. Sokolov
- Department of Biophysics, Federal Research and Clinical Center of Physical-Chemical Medicine of Federal Medical Biological Agency, Moscow 119435, Russia
- Department of Molecular Genetics, Institute of Experimental Medicine, St. Petersburg 197376, Russia
| |
Collapse
|
2
|
Gorudko IV, Grigorieva DV, Shamova EV, Gorbunov NP, Kokhan AU, Kostevich VA, Vasilyev VB, Panasenko OM, Khinevich NV, Bandarenka HV, Burko AA, Sokolov AV. Structure-biological activity relationships of myeloperoxidase to effect on platelet activation. Arch Biochem Biophys 2022; 728:109353. [PMID: 35853481 DOI: 10.1016/j.abb.2022.109353] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/23/2022] [Revised: 06/28/2022] [Accepted: 07/11/2022] [Indexed: 11/26/2022]
Abstract
Myeloperoxidase (MPO), an oxidant-producing enzyme of neutrophils, has been shown to prime platelet activity promoting immunothrombosis. Native MPO is a homodimer, consisting of two identical protomers (monomer) connected by a single disulfide bond. But in inflammatory foci, MPO can be found both in the form of a monomer and in the form of a dimer. Beside MPO can also be in complexes with other molecules and be modified by oxidants, which ultimately affect its physicochemical properties and functions. Here we compared the effects of various forms of MPO as well as MPO in complex with ceruloplasmin (CP), a physiological inhibitor of MPO, on the platelet activity. Monomeric MPO (hemi-MPO) was obtained by treating the dimeric MPO by reductive alkylation. MPO was modified with HOCl in a molar ratio of 1:100 (MPO-HOCl). Using surface-enhanced Raman scattering (SERS) spectroscopy we showed that peaks at about 510 and 526 cm-1 corresponded to disulfide bond was recognizable in the SERS-spectra of dimeric MPO, absent in the spectrum of hemi-MPO and less intense in the spectra of MPO-HOCl, which indicates the partial decomposition of dimeric MPO with a disulfide bond cleavage under the HOCl modification. It was shown hemi-MPO to a lesser extent than dimeric MPO bound to platelets and enhanced their agonist-induced aggregation and platelet-neutrophil aggregate formation. MPO modified by HOCl and MPO in complex with CP did not bind to platelets and have no effect on platelet activity. Thus, the modification of MPO by HOCl, its presence in monomeric form as well as in complex with CP reduces MPO effect on platelet function and consequently decreases the risk of thrombosis in inflammatory foci.
Collapse
Affiliation(s)
- I V Gorudko
- Department of Biophysics, Faculty of Physics, Belarusian State University, 4 Nezavisimosti Avenue, Minsk, 220030, Belarus.
| | - D V Grigorieva
- Department of Biophysics, Faculty of Physics, Belarusian State University, 4 Nezavisimosti Avenue, Minsk, 220030, Belarus
| | - E V Shamova
- Institute of Biophysics and Сell Engineering of National Academy of Sciences of Belarus, 27 Academicheskaya Str., Minsk, 220072, Belarus
| | - N P Gorbunov
- FSBRI "Institute of Experimental Medicine", 12 Acad. Pavlov Str., St. Petersburg, 197376, Russia; Federal Research and Clinical Center of Physical-Chemical Medicine of Federal Medical Biological Agency, 1a Malaya Pirogovskaya Str., Moscow, 119435, Russia
| | - A U Kokhan
- Institute of Biophysics and Сell Engineering of National Academy of Sciences of Belarus, 27 Academicheskaya Str., Minsk, 220072, Belarus
| | - V A Kostevich
- FSBRI "Institute of Experimental Medicine", 12 Acad. Pavlov Str., St. Petersburg, 197376, Russia; Federal Research and Clinical Center of Physical-Chemical Medicine of Federal Medical Biological Agency, 1a Malaya Pirogovskaya Str., Moscow, 119435, Russia
| | - V B Vasilyev
- FSBRI "Institute of Experimental Medicine", 12 Acad. Pavlov Str., St. Petersburg, 197376, Russia
| | - O M Panasenko
- Federal Research and Clinical Center of Physical-Chemical Medicine of Federal Medical Biological Agency, 1a Malaya Pirogovskaya Str., Moscow, 119435, Russia; Pirogov Russian National Research Medical University, 1 Ostrovityanova Str., Moscow, 117997, Russia
| | - N V Khinevich
- Belarusian State University of Informatics and Radioelectronics, 6 P. Brovka Str., Minsk, 220013, Belarus; Institute of Materials Science, Kaunas University of Technology, K. Donelaičio g. 73, Kaunas, 44249, Lithuania
| | - H V Bandarenka
- Belarusian State University of Informatics and Radioelectronics, 6 P. Brovka Str., Minsk, 220013, Belarus; Polytechnic School, Arizona State University, Arizona State University Polytechnicm, 7001 East Williams Field Road, Mesa, AZ, 85212, USA
| | - A A Burko
- Belarusian State University of Informatics and Radioelectronics, 6 P. Brovka Str., Minsk, 220013, Belarus; Polytechnic School, Arizona State University, Arizona State University Polytechnicm, 7001 East Williams Field Road, Mesa, AZ, 85212, USA
| | - A V Sokolov
- FSBRI "Institute of Experimental Medicine", 12 Acad. Pavlov Str., St. Petersburg, 197376, Russia; Federal Research and Clinical Center of Physical-Chemical Medicine of Federal Medical Biological Agency, 1a Malaya Pirogovskaya Str., Moscow, 119435, Russia
| |
Collapse
|
3
|
Sokolov A, Kostevich V, Varfolomeeva E, Grigorieva D, Gorudko I, Kozlov S, Kudryavtsev I, Mikhalchik E, Filatov M, Cherenkevich S, Panasenko O, Arnhold J, Vasilyev V. Capacity of ceruloplasmin to scavenge products of the respiratory burst of neutrophils is not altered by the products of reactions catalyzed by myeloperoxidase. Biochem Cell Biol 2018; 96:457-467. [DOI: 10.1139/bcb-2017-0277] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/16/2022] Open
Abstract
CP is a copper-containing ferroxidase of blood plasma, which acts as an acute phase reactant during inflammation. The effect of oxidative modification of CP induced by oxidants produced by MPO, such as HOCl, HOBr, and HOSCN, on its spectral, enzymatic, and anti-inflammatory properties was studied. We monitored the chemiluminescence of lucigenin and luminol along with fluorescence of hydroethidine and scopoletin to assay the inhibition by CP of the neutrophilic respiratory burst induced by PMA or fMLP. Superoxide dismutase activity of CP and its capacity to reduce the production of oxidants in respiratory burst of neutrophils remained virtually unchanged upon modifications caused by HOCl, HOBr, and HOSCN. Meanwhile, the absorption of type I copper ions at 610 nm became reduced, along with a drop in the ferroxidase and amino oxidase activities of CP. Likewise, its inhibitory effect on the halogenating activity of MPO was diminished. Sera of either healthy donors or patients with Wilson disease were co-incubated with neutrophils from healthy volunteers. In these experiments, we observed an inverse relationship between the content of CP in sera and the rate of H2O2 production by activated neutrophils. In conclusion, CP is likely to play a role of an anti-inflammatory factor tempering the neutrophil respiratory burst in the bloodstream despite the MPO-mediated oxidative modifications.
Collapse
Affiliation(s)
- A.V. Sokolov
- FSBSI Institute of Experimental Medicine, Saint-Petersburg 197376, Russia
- Federal Research and Clinical Center of Physical-Chemical Medicine of Federal Medical Biological Agency, Moscow 119435, Russia
- Saint-Petersburg State University, Saint-Petersburg 199034, Russia
- Centre of Preclinical Translational Research, Almazov National Medical Research Centre, Saint-Petersburg 197371, Russia
| | - V.A. Kostevich
- FSBSI Institute of Experimental Medicine, Saint-Petersburg 197376, Russia
- Federal Research and Clinical Center of Physical-Chemical Medicine of Federal Medical Biological Agency, Moscow 119435, Russia
| | - E.Y. Varfolomeeva
- National Research Centre “Kurchatov Institute” B.P. Konstantinov Petersburg Nuclear Physics Institute, Gatchina 188300, Russia
| | - D.V. Grigorieva
- Department of Biophysics, Belarusian State University, Minsk 220030, Belarus
| | - I.V. Gorudko
- Department of Biophysics, Belarusian State University, Minsk 220030, Belarus
| | - S.O. Kozlov
- FSBSI Institute of Experimental Medicine, Saint-Petersburg 197376, Russia
| | - I.V. Kudryavtsev
- FSBSI Institute of Experimental Medicine, Saint-Petersburg 197376, Russia
- Far Eastern Federal University, Vladivostok 690090, Russia
| | - E.V. Mikhalchik
- Federal Research and Clinical Center of Physical-Chemical Medicine of Federal Medical Biological Agency, Moscow 119435, Russia
| | - M.V. Filatov
- National Research Centre “Kurchatov Institute” B.P. Konstantinov Petersburg Nuclear Physics Institute, Gatchina 188300, Russia
| | - S.N. Cherenkevich
- Department of Biophysics, Belarusian State University, Minsk 220030, Belarus
| | - O.M. Panasenko
- Federal Research and Clinical Center of Physical-Chemical Medicine of Federal Medical Biological Agency, Moscow 119435, Russia
- Pirogov Russian National Research Medical University, Moscow 117997, Russia
| | - J. Arnhold
- Institute for Medical Physics and Biophysics, Medical Faculty, University of Leipzig, Leipzig 04107, Germany
| | - V.B. Vasilyev
- FSBSI Institute of Experimental Medicine, Saint-Petersburg 197376, Russia
- Saint-Petersburg State University, Saint-Petersburg 199034, Russia
| |
Collapse
|
4
|
Vlasova II, Mikhalchik EV, Gusev AA, Balabushevich NG, Gusev SA, Kazarinov KD. Extremely high-frequency electromagnetic radiation enhances neutrophil response to particulate agonists. Bioelectromagnetics 2017; 39:144-155. [PMID: 29194676 DOI: 10.1002/bem.22103] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/26/2017] [Accepted: 11/14/2017] [Indexed: 11/12/2022]
Abstract
The growing use of extremely high-frequency electromagnetic radiation (EHF EMR) in information and communication technology and in biomedical applications has raised concerns regarding the potential biological impact of millimeter waves (MMWs). Here, we elucidated the effects of MMW radiation on neutrophil activation induced by opsonized zymosan or E. coli in whole blood ex vivo. After agonist addition to blood, two samples were prepared. A control sample was incubated at ambient conditions without any treatment, and a test sample was exposed to EHF EMR (32.9-39.6 GHz, 100 W/m2 ). We used methods that allowed us to assess the functional status of neutrophils immediately after exposure: oxidant production levels were measured by luminol-dependent chemiluminescence, and morphofunctional changes to neutrophils were observed in blood smears. Results revealed that the response of neutrophils to both agonists was intensified if blood was exposed to MMW radiation for 15 min. Neutrophils were intact in both the control and irradiated samples if no agonist was added to blood before incubation. Similarly, exposing suspensions of isolated neutrophils in plasma to MMW radiation enhanced cell response to both zymosan and E. coli. Heating blood samples was shown to be the primary mechanism underlying enhanced EHF EMR-induced oxidant production by neutrophils in response to particulate agonists. Bioelectromagnetics. 39:144-155, 2018. © 2017 Wiley Periodicals, Inc.
Collapse
Affiliation(s)
- Irina I Vlasova
- Research and Clinical Center for Physico-Chemical Medicine, Moscow, Russia.,Kotel'nikov Institute of Radioengineering and Electronics of Russian Academy of Sciences (Fryasino branch), Fryasino, Russia
| | - Elena V Mikhalchik
- Research and Clinical Center for Physico-Chemical Medicine, Moscow, Russia
| | - Alexandr A Gusev
- Research and Clinical Center for Physico-Chemical Medicine, Moscow, Russia
| | | | - Sergey A Gusev
- Research and Clinical Center for Physico-Chemical Medicine, Moscow, Russia
| | - Konstantin D Kazarinov
- Kotel'nikov Institute of Radioengineering and Electronics of Russian Academy of Sciences (Fryasino branch), Fryasino, Russia
| |
Collapse
|
5
|
Del Giudice A, Dicko C, Galantini L, Pavel NV. Structural Response of Human Serum Albumin to Oxidation: Biological Buffer to Local Formation of Hypochlorite. J Phys Chem B 2016; 120:12261-12271. [DOI: 10.1021/acs.jpcb.6b08601] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/28/2023]
Affiliation(s)
- Alessandra Del Giudice
- Department
of Chemistry, Sapienza University of Rome, P. le A. Moro 5, 00185 Rome, Italy
| | - Cedric Dicko
- Department
of Chemistry, Division for Pure and Applied Biochemistry, Lund University, Naturvetarvägen 14, 2241 Lund, Sweden
| | - Luciano Galantini
- Department
of Chemistry, Sapienza University of Rome, P. le A. Moro 5, 00185 Rome, Italy
| | - Nicolae V. Pavel
- Department
of Chemistry, Sapienza University of Rome, P. le A. Moro 5, 00185 Rome, Italy
| |
Collapse
|
6
|
Mikhalchik EV, Budkevich LI, Piterskaya YA, Penkov LY, Astamirova TS, Smolina NV, Vakhrusheva TV, Panasenko OM. [The role of neutrophil myeloperoxidase in the development of inflammation after thermal skin burns]. BIOMEDIT︠S︡INSKAI︠A︡ KHIMII︠A︡ 2016; 62:584-587. [PMID: 27797335 DOI: 10.18097/pbmc20166205584] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/23/2022]
Abstract
In the blood of children (n=16) with large thermal skin burns (> 20% of total body surface), luminol-dependent chemiluminescence (CL) of neutrophils stimulated with phorbol-12-myristate-13-acetate (PMA) and myeloperoxidase (MPO) activity in neutrophils and plasma were assayed in the early period (1-7 post-burn days). PMA-stimulated neutrophils in thermally injured patients produced higher CL than those in a reference group of healthy children (n=24), p<0.01. MPO activity was elevated in neutrophils and plasma in 40% and 57% of patients' blood samples, respectively. The albumin fraction isolated from plasma of burned patients enhanced the PMA-stimulated CL response of blood samples from healthy volunteer. Our results suggest that the acute inflammatory response induced by thermal injury involves activation of neutrophils and is accompanied by MPO release into the plasma. MPO-mediated modification of serum albumin induces its capacity to prime neutrophils and thus to enhance further inflammatory reaction.
Collapse
Affiliation(s)
- E V Mikhalchik
- Federal Scientific Clinical Centre of Physical Chemical Medicine, Moscow, Russia
| | - L I Budkevich
- Speransky Pediatric Clinical Hospital No.9, Moscow, Russia
| | | | - L Yu Penkov
- Speransky Pediatric Clinical Hospital No.9, Moscow, Russia
| | - T S Astamirova
- Speransky Pediatric Clinical Hospital No.9, Moscow, Russia
| | - N V Smolina
- Federal Scientific Clinical Centre of Physical Chemical Medicine, Moscow, Russia
| | - T V Vakhrusheva
- Federal Scientific Clinical Centre of Physical Chemical Medicine, Moscow, Russia
| | - O M Panasenko
- Federal Scientific Clinical Centre of Physical Chemical Medicine, Moscow, Russia
| |
Collapse
|
7
|
Panasenko OM, Mikhalchik EV, Gorudko IV, Grigorieva DV, Sokolov AV, Kostevich VA, Vasilyev VB, Cherenkevich SN. The effects of antioxidants and hypohalous acid scavengers on neutrophil activation by hypochlorous acid-modified low-density lipoproteins. Biophysics (Nagoya-shi) 2016. [DOI: 10.1134/s0006350916030131] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022] Open
|